AVNS
Avanos Medical Stock Analysis
AI Rating
- Quality2/10
- Growth↓ 1/10
- Value↓ 2/10
AVNS Growth
- Revenue Y/Y↓ 2.76%
- EPS Y/Y↑ 80.88%
- FCF Y/Y↓ -89.91%
AVNS Profitability
- Gross margin ↑ 50.00%
- EPS margin↓ -10.40%
- ROIC 5Y↓ -32.21%
AVNS Risk
- Debt / Equity↓ 0.2
- Debt / FCF↑ 6.3
- Interest coverage↓ -8.5
Avanos Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.